Scott Kaiser is currently the Associate Director of Clinical Development in Neuroscience at Eli Lilly and Company, where they manage multiple strategic operations and implement diverse trial management strategies. They have previously held roles in data and analytics and clinical data management at Eli Lilly. With a strong foundation in project management from Indiana University School of Medicine, Scott oversaw the BioSEND initiative focused on Parkinson's and Huntington disease research. They hold an MBA in Finance from the Kelley School of Business and a B.S. in Biology from Indiana University Bloomington. Known for their effective management style and strong customer service skills, Scott has built a reputation for increasing performance and enhancing collaboration across various departmental functions.
This person is not in any teams
This person is not in any offices